Literature DB >> 12823708

p57kip2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles.

S-Y Jun1, J Y Ro, K-R Kim.   

Abstract

AIMS: To determine the utility of p57kip2 in the diagnosis of hydatidiform mole. p57kip2 protein is a cyclin-dependent kinase inhibitor (CDKI) and is strongly paternally imprinted, being expressed from the maternal allele. It has been hypothesized that complete mole (CHM) with only the paternal genome would display reduced or nearly absent expression of p57kip2 compared to partial mole (PHM) having both paternal and maternal genomes. METHODS AND
RESULTS: The immunohistochemical expression of p57kip2 protein was investigated using paraffin-embedded tissue sections in histologically unequivocal cases of CHM (n = 51), PHM (n = 7), invasive mole (n = 1), and hydropic miscarriage (n = 2), as well as in histologically undetermined cases (n = 9). In the histologically unequivocal complete and invasive moles, expression of p57kip2 was absent except for one case in which villous cytotrophoblast covering the villous stroma was positive (51/52) as well as villous stromal cells (51/52). In contrast, it was strongly and continuously expressed in both villous cytotrophoblast and stromal cells in all cases of PHM and hydropic miscarriage. Among the nine histologically undetermined cases, five cases showing p57kip2 immunopositivity and hyperploid DNA were classified as PHMs, two cases showing p57kip2 immunonegativity and hyperploidy as CHMs, and two cases with p57kip2 immunopositivity and diploid DNA as hydropic miscarriage and diploid PHM, respectively, upon review of the histopathological findings. Intermediate trophoblast forming trophoblastic columns or anchoring villi and extravillous trophoblast at the implantation site showed variable expression of p57kip2 in all gestational conditions. Maternal decidua showed diffuse and strong p57kip2 expression, whereas syncytiotrophoblast was completely negative in all cases regardless of the diagnosis.
CONCLUSIONS: In summary, p57kip2 immunostaining results correlated well with morphological features of molar pregnancies and were helpful in determining histologically equivocal cases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12823708     DOI: 10.1046/j.1365-2559.2003.01667.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  9 in total

1.  Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis.

Authors:  Russell Vang; Mamta Gupta; Lee-Shu-Fune Wu; Anna V Yemelyanova; Robert J Kurman; Kathleen M Murphy; Cheryl Descipio; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2012-03       Impact factor: 6.394

2.  Activation of the canonical wingless/T-cell factor signaling pathway promotes invasive differentiation of human trophoblast.

Authors:  Jürgen Pollheimer; Thomas Loregger; Stefan Sonderegger; Leila Saleh; Sandra Bauer; Martin Bilban; Klaus Czerwenka; Peter Husslein; Martin Knöfler
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

3.  Expression of p57KIP2 in infantile hemangioma.

Authors:  Ricardo Drut; Rosa Mónica Drut
Journal:  J Mol Histol       Date:  2005-03       Impact factor: 2.611

4.  Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis for both recently trained and experienced gynecologic pathologists.

Authors:  Mamta Gupta; Russell Vang; Anna V Yemelyanova; Robert J Kurman; Fanghong Rose Li; Emily C Maambo; Kathleen M Murphy; Cheryl DeScipio; Carol B Thompson; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2012-12       Impact factor: 6.394

5.  Immunohistochemical Analysis of E-Cadherin, p53 and Inhibin-α Expression in Hydatidiform Mole and Hydropic Abortion.

Authors:  Onur Erol; Dinç Süren; Birsel Tutuş; Tayfun Toptaş; Ahmet Arda Gökay; Aysel Uysal Derbent; Mustafa Kemal Özel; Cem Sezer
Journal:  Pathol Oncol Res       Date:  2015-12-18       Impact factor: 3.201

6.  DNAse I pre-treatment markedly enhances detection of nuclear cyclin-dependent kinase inhibitor p57Kip2 and BrdU double immunostaining in embryonic rat brain.

Authors:  Weizhen Ye; Georges Mairet-Coello; Emanuel DiCicco-Bloom
Journal:  Histochem Cell Biol       Date:  2006-10-06       Impact factor: 4.304

7.  P57kip2 immunohistochemical expression and ultrastructural findings of gestational trophoblastic disease and related disorders.

Authors:  Hiroaki Soma; Hiroyuki Osawa; Tatsuo Oguro; Isao Yoshihama; Koji Fujita; Shoichiro Mineo; Motoshige Kudo; Kayoko Tanaka; Masumi Akita; Satoshi Urabe; Yoshiki Kudo
Journal:  Med Mol Morphol       Date:  2007-06-18       Impact factor: 2.309

8.  Clinical Usefulness of Immunohistochemical Staining of p57 kip2 for the Differential Diagnosis of Complete Mole.

Authors:  Shigeru Sasaki; Yasushi Sasaki; Toshiaki Kunimura; Akihiko Sekizawa; Yoshihiro Kojima; Koichi Iino
Journal:  Biomed Res Int       Date:  2015-06-16       Impact factor: 3.411

9.  p57 in Hydatidiform Moles: Evaluation of Antibodies and Expression in Various Cell Types.

Authors:  Helle Lund; Søren Nielsen; Anni Grove; Mogens Vyberg; Lone Sunde
Journal:  Appl Immunohistochem Mol Morphol       Date:  2020-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.